Glutarate

Glutarate

SCHEMBL4768243

O=C(O)C(F)(F)F.O=C(O)CCCC(=O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.65
LMNA P02545 4/20 0.56
TSHR P16473 4/20 0.53
NFKB1 P19838 2/20 0.53
PMP22 Q01453 1/20 0.53
CAMK2A Q9UQM7 1/20 0.48
HDAC11 Q96DB2 2/20 0.46
GABRR3 A8MPY1 1/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
HDAC3 O15379 1/20 0.46
GABBR2 O75899 1/20 0.46
CYP1A2 P05177 1/20 0.46
THRB P10828 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRR1 P24046 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRR2 P28476 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL29896408 0.88 LMNA (0.60) SLC22A6LMNATSHRNFKB1PMP22
Succinic Acid SCHEMBL29896406 0.88 LMNA (0.60) SLC22A6LMNATSHRNFKB1PMP22
Gamma-Aminobutyric Acid SCHEMBL9049554 0.85 LMNA (0.71) SLC22A6LMNATSHRNFKB1PMP22
Valeric Acid SCHEMBL27502000 0.85 AKR1B1 (0.61) SLC22A6TSHRHDAC11KMT2AGPR84
SCHEMBL23896902 0.83 SLC22A6 (0.58) SLC22A6LMNATSHRNFKB1PMP22
5-Aminovaleric Acid SCHEMBL28804498 0.83 NFKB1 (0.73) SLC22A6LMNATSHRNFKB1PMP22
Nonanoate SCHEMBL23043748 0.81 GPR84 (0.74) SLC22A6TSHRHDAC11CYP1A2KMT2A
Nonanoate SCHEMBL23043798 0.81 GPR84 (0.74) SLC22A6TSHRHDAC11CYP1A2KMT2A
Glutarate SCHEMBL6701735 0.80
Glutarate SCHEMBL7414 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102858159-A Chemical compounds GLAXOSMITHKLINE LLC 2013-01-02 CN disclosed
EP-1648873-A4 NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS FOR THEIR USE NEUREN PHARMACEUTICALS LTD (NZ) 2008-06-25 EP disclosed
EP-1648873-A2 NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS FOR THEIR USE Neuronz Limited (NZ) 2006-04-26 EP disclosed
WO-2004084809-A2 NEUROPROTECTIVE MACROCYLIC COMPOUNDS AND METHODS FOR THEIR USE NEUREN PHARMACEUTICALS LTD. (NZ) 2004-10-07 WO disclosed